Corporates - Immunology

A total of 601 corporates are partnering with Digital Health ventures that are operating within the Immunology therapeutic area.

These stakeholders have closed a total of 827 partnerships. Their partner Digital Health ventures have an average maturity score of 273.0. Companies within this space partner primarily with ventures within the Research Solutions Digital Health cluster.

Last Updated: August 22, 2026

Corporates

Result: 601

Corporate Name	Number of Partners	Partners
Pfizer	19	XtalPi (晶泰科技), AbCellera, asddswdsfd , asddswdsfd View All
Eli Lilly and Company	15	XtalPi (晶泰科技), AbCellera, asddswdsfd , asddswdsfd View All
AstraZeneca	13	BrightInsight, Absci, asddswdsfd , asddswdsfd View All
Sanofi	12	BrightInsight, Absci, asddswdsfd , asddswdsfd View All
Y Combinator	11	Cofactor Genomics, 1910 Genetics, asddswdsfd , asddswdsfd View All
AbbVie	9	AbCellera, Jumo Health, asddswdsfd , asddswdsfd View All
MSD	7	AbCellera, Absci, asddswdsfd , asddswdsfd View All
Johnson & Johnson Innovative Medicine	7	XtalPi (晶泰科技), BigHat Biosciences, asddswdsfd , asddswdsfd View All
Roche	7	Blueprint Medicines, BrightInsight, asddswdsfd , asddswdsfd View All
Novartis	7	HiFiBiO Therapeutics, Biognosys, asddswdsfd , asddswdsfd View All

Showing 1 to 10 of 601 entries